[{"NetIncomeLoss_2_Q2_USD":-49704000.0,"InterestAndOtherIncome_1_Q2_USD":429000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"OperatingLeasesRentExpenseNet_2_Q2_USD":500000.0,"OperatingLeasesRentExpenseNet_1_Q2_USD":300000.0,"TreasuryStockCommonShares_0_Q2_shares":0.0,"InterestPaidNet_2_Q2_USD":1495000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":229000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":31600000.0,"RegulatoryLiabilityCurrent_0_Q2_USD":576000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":22064000.0,"Depreciation_2_Q2_USD":200000.0,"Depreciation_1_Q2_USD":100000.0,"GrantsReceivable_0_Q2_USD":1600000.0,"PaymentsToAcquireInvestments_2_Q2_USD":56436000.0,"InterestAndOtherIncome_2_Q2_USD":1395000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":18245000.0,"AssetsCurrent_0_Q2_USD":255436000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":18900000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":1689000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":12411863.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":12411863.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":290000.0,"FinanceLeaseInterestExpense_2_Q2_USD":607000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":445000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":35911000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":805000.0,"CommonStockSharesIssued_0_Q2_shares":55170003.0,"Assets_0_Q2_USD":353065000.0,"UnrealizedGainLossOnInvestments_2_Q2_USD":209000.0,"ShareBasedCompensation_2_Q2_USD":8450000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":75000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":55158459.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":55020789.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6828000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":450000.0,"ClassOfWarrantOrRightOutstanding_0_Q2_shares":14102.0,"ResearchAndDevelopmentExpense_2_Q2_USD":33687000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":16731000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1652000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":265000.0,"CommonStockValue_0_Q2_USD":551000.0,"DepositsAssetsNoncurrent_0_Q2_USD":455000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":-3188000.0,"InterestPayableCurrent_0_Q2_USD":1252000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":242000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":34000.0,"RestrictedCashEquivalentsNoncurrent_0_Q2_USD":1525000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q2_USD":56432000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":249800000.0,"FairValueOfAssetsAcquired_2_Q2_USD":3958000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":1644000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":13990000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":46228000.0,"OperatingLeaseLiability_0_Q2_USD":1525000.0,"TreasuryStockCommonValue_0_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":304000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":209000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1270000.0,"FinanceLeaseLiability_0_Q2_USD":20521000.0,"Liabilities_0_Q2_USD":86542000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":706000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":163203000.0,"ProceedsFromSaleOfTreasuryStock_2_Q2_USD":591000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-24736000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-49495000.0,"ConstructionPayableCurrent_0_Q2_USD":3958000.0,"ShortTermInvestments_0_Q2_USD":86600000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PaymentsToAcquireSoftware_2_Q2_USD":368000.0,"CommonStockSharesOutstanding_0_Q2_shares":55170003.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1141000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0896,"Goodwill_0_Q2_USD":30815000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":538000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4489000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-44278000.0,"DefinedContributionPlanEmployerMatchingContributionPercent_2_Q2_pure":0.04,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":682000.0,"LiabilitiesCurrent_0_Q2_USD":20685000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-22180000.0,"PaymentsOfDebtIssuanceCosts_2_Q2_USD":237000.0,"InterestExpense_2_Q2_USD":3360000.0,"InterestExpense_1_Q2_USD":1786000.0,"LeaseCost_2_Q2_USD":1668000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":164728000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":3000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_2_Q2_USD":186000.0,"DefinedContributionPlanEmployerDiscretionaryContributionAmount_1_Q2_USD":87000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":315000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":1736000.0,"FinanceLeaseRightOfUseAssetAmortization_2_Q2_USD":655000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.0777,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":1791000.0,"AdditionalPaidInCapital_0_Q2_USD":498590000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q2_USD":24.82,"OperatingLeasePayments_2_Q2_USD":447000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":122000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":14314000.0,"NetIncomeLoss_1_Q2_USD":-25040000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":5633000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-232847000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":88714000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q2_USD":-124000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":127000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2522000.0,"CommonStockSharesAuthorized_0_Q2_shares":120000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":0.0,"ImpairmentOfLongLivedAssetsHeldForUse_2_Q2_USD":62000.0,"OperatingIncomeLoss_2_Q2_USD":-47677000.0,"OperatingIncomeLoss_1_Q2_USD":-23559000.0,"PaymentsForRepurchaseOfCommonStock_2_Q2_USD":72000.0,"OperatingLeaseCost_2_Q2_USD":407000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":353065000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2072000.0,"PreferredStockSharesAuthorized_0_Q2_shares":5000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":8450000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4489000.0,"FinanceLeaseRightOfUseAsset_0_Q2_USD":49250000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-62000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":7115000.0,"StockholdersEquity_0_Q2_USD":266523000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":1621000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":23000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.9,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":287000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.45,"OperatingExpenses_2_Q2_USD":47677000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2_Q2_USD":20179000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":819000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":15455000.0,"StockIssuedDuringPeriodValueTreasuryStockReissued_1_Q2_USD":538000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":1416000.0,"OperatingExpenses_1_Q2_USD":23559000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":784000.0,"Ticker":"RCKT","CIK":"1281895","name":"ROCKET PHARMACEUTICALS, INC.","OfficialName":"Rocket Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"879860326.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]